Taiwan Bio Therapeutics (ROCO:6892) FCF Yield % : -12.60 (As of Jun. 30, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Taiwan Bio Therapeutics's Trailing 12-Month Free Cash Flow is NT$-354.1 Mil, and Market Cap is NT$2,809.0 Mil. Therefore, Taiwan Bio Therapeutics's FCF Yield % for today is -12.60%.

The historical rank and industry rank for Taiwan Bio Therapeutics's FCF Yield % or its related term are showing as below:

ROCO:6892' s FCF Yield % Range Over the Past 10 Years
Min: -14.65 Med: -8.62 Max: -2.91
Current: -12.6

During the past 6 years, the highest FCF Yield % of Taiwan Bio Therapeutics was -2.91%. The lowest was -14.65%. And the median was -8.62%.

ROCO:6892's FCF Yield % is ranked better than
51.31% of 1489 companies
in the Biotechnology industry
Industry Median: -13.23 vs ROCO:6892: -12.60

Taiwan Bio Therapeutics's FCF Margin % for the quarter that ended in Mar. 2025 was -567.77%.

Taiwan Bio Therapeutics FCF Yield % Historical Data

The historical data trend for Taiwan Bio Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics FCF Yield % Chart

Taiwan Bio Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-13.62

-13.55

-10.49

Taiwan Bio Therapeutics Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
FCF Yield %	Get a 7-Day Free Trial								-11.65	-14.90	-10.22	-11.09	-8.85

Competitive Comparison of Taiwan Bio Therapeutics's FCF Yield %

For the Biotechnology subindustry, Taiwan Bio Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taiwan Bio Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Bio Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Taiwan Bio Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Taiwan Bio Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Taiwan Bio Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-363.255	/	3463.762
	=	-10.49%

Taiwan Bio Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2025 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-64.981	*	4	/	2935.7495
	=	-8.85%

Taiwan Bio Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Taiwan Bio Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744

Website

https://www.twbio-thera.com

Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines